Wikidata

(Q62105825)

English

Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer

clinical trial

In more languages

Statements

title
Phase I Trial of Intravenous Fenretinide (4-HPR) for Patients With Hematologic Malignancies (English)
0 references
medical condition
lymphoma
0 references
leukemia
0 references
multiple myeloma
0 references
plasmacytoma
0 references
main subject
Scotland
0 references
start time
February 2005
0 references
end time
April 2017
0 references
number of participants
29
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q62105825&oldid=2149165164"